Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$0 Mln
Revenue (TTM)
$20 Mln
Net Profit (TTM)
$0 Mln
ROE
-0.5 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
0.2
Industry P/E
--
EV/EBITDA
9.7
Div. Yield
0 %
Debt to Equity
-3.1
Book Value
$--
EPS
$-0.3
Face value
--
Shares outstanding
29,912,305
CFO
$-423.26 Mln
EBITDA
$-395.81 Mln
Net Profit
$-513.83 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Acutus Medical Inc (AFIB)
| -- | -- | -- | -99.8 | -94.9 | -90.6 | -- |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|
|
Acutus Medical Inc (AFIB)
| -72.5 | -82.4 | -66.3 | -88.2 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Acutus Medical Inc (AFIB)
|
0.0 | 0.0 | 20.2 | -9.6 | 6.1 | 153.1 | -- | 0.2 |
| 7.9 | 5,388.2 | 6,552.2 | -530.2 | -4.1 | -9.2 | -- | 0.9 | |
| 278.3 | 7,510.1 | 2,583.2 | 759.9 | 25.2 | 10.8 | 10 | 1.0 | |
| 36.8 | 5,222.6 | 3,436.5 | -8.6 | 2.2 | -0.4 | -- | 2.1 | |
| 112.8 | 6,549.6 | 507.4 | -187.7 | -36.2 | -26.4 | -- | 10.0 | |
| 76.1 | 4,758.4 | 1,541.6 | 233.6 | 21.6 | 21.4 | 21.4 | 4.5 | |
| 178.6 | 9,411.8 | 1,526.9 | -151.5 | 20.0 | -17.1 | -- | 12.9 | |
| 330.4 | 12,964.3 | 1,403.7 | 177.7 | 14.7 | 13.8 | 72.9 | 9.0 | |
| 117.8 | 6,280.4 | 738.3 | 48.9 | 11.4 | 2.4 | 129.6 | 3.0 | |
| 32.1 | 13,716.9 | 6,178.4 | 626.5 | 13.0 | 11.9 | 22.5 | 2.6 |
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal... crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California. Read more
CEO & CFO
Mr. Takeo Mukai
CEO & CFO
Mr. Takeo Mukai
Headquarters
Carlsbad, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Acutus Medical Inc (AFIB) is $0.00 (NASDAQ) as of 02-Apr-2026 09:30 EDT. Acutus Medical Inc (AFIB) has given a return of -94.9% in the last 3 years.
Since, TTM earnings of Acutus Medical Inc (AFIB) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
-0.17
|
-0.14
|
|
2023
|
-0.07
|
-6.74
|
|
2022
|
-1.08
|
0.57
|
|
2021
|
-0.81
|
0.90
|
|
2020
|
-7.88
|
6.35
|
The 52-week high and low of Acutus Medical Inc (AFIB) are Rs 0.05 and Rs 0.00 as of 05-Apr-2026.
Acutus Medical Inc (AFIB) has a market capitalisation of $ 0 Mln as on 27-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Acutus Medical Inc (AFIB), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-0.03
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.